Acne Vulgaris on the Face
5
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
6 treatments under study, led by At004
Research Leaders
7 sponsors active, led by Ghurki Trust and Teaching Hospital
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
40%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (5)
Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris
Safety and Efficacy of Topical AT-004 1% in Participants With Acne Vulgaris (AV)
Efficacy of Oral Metformin vs Oral Doxycycline in Treating Acne Vulgaris
Efficacy and Tolerability of DispersinB Acne Cleanser in the Treatment of Mild to Moderate Acne Vulgaris
Efficacy of a Deep Cleansing Gel Containing 2% Salicylic Acid, 0.2% Zinc Gluconate and 0.05% Lipohydroxy Acid in the Management of Mild to Moderate Facial Acne
Research Network
Common Treatments
- At0041
- Dispersinb Acne Cleanser1
- Experimental Drug Cyproterone Acetate 2 Mg And Ethinyl Estradiol 002 Mg1
- Dermocosmetic1
- Doxycycline1
Active Sponsors
- Ghurki Trust and Teaching Hospital1
- Arctic Therapeutics1
- Cosmetique Active International1
- Blueskin AS1
- University of Miami1
Top Investigators
Lahore Medical and Dental College
Ghurki Trust Teaching Hospital
Ghurki Trust Teaching Hospital
Lahore Medical and Dental College
Ghurki Trust Teaching Hospital
Related Conditions
- Acne Vulgaris3